You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 31 - 40 of 8806 results
  1. Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase

    SBC: AFASCI, INC.            Topic: 150

    7. SUMMARY Alcohol use disorder (AUD) is the most prevalent substance use disorder worldwide and often co-occurs with chronic pain, anxiety, depression, and opioid dependence. Unfortunately, currently available medications for AUD have limited efficacy with unwanted side effects. To address this unmet medical need, we propose an SBIR Phase I U43 project in response to PAR-22-102 "Investigational N ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Preclinical validation of mGlu2 PAMs in alcohol use disorder

    SBC: Camino Pharma, LLC            Topic: 150

    PROJECT SUMMARY Alcohol Use Disorder (AUD) continues to be a significant problem, affecting 28.3 million adults in the United States, and is the third leading preventable cause of death. Disulfiram, naltrexone, and acamprosate are the only drugs approved by the Food and Drug Administration, but all three have limited efficacy and several contraindications. Given the substantial burden on society a ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. Multisensory Augmented Reality as a bridge to audio-only accommodations for inclusive STEM interactive digital media

    SBC: ALCHEMIE SOLUTIONS, INC.            Topic: 500

    Only 3% of individuals who are blind or have low vision (BLV) have been employed in a STEM field. The lack of accessible accommodations to visually rich dynamic STEM content creates roadblocks to success for BLV students in STEM education throughout their academic journey. The goal of this SBIR is a usable system of accommodations for Interactive Digital Media (IDM), so students with profound visu ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Targeting TLR4-lipid rafts to prevent postoperative pain

    SBC: RAFT PHARMACEUTICALS LLC            Topic: 108

    PROJECT SUMMARY Postoperative pain is a prevalent source of pain requiring appropriate management to reduce its impact upon quality of life. Even with the availability of several analgesics, postoperative pain is often undermedicated because of concern related to the adverse consequence of the available therapeutics (e.g., NSAIDs and opiates), including addiction and decreased survival of cancer p ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  5. PANK Activators for the treatment of pantothenate kinase-associated neurodegeneration

    SBC: Virtus Therapeutics Corporation            Topic: NINDS

    SUMMARY Pantothenate kinase-associated neurodegeneration, PKAN, is a rare progressive neurodegenerative disorder associated with iron accumulation in the brain. The disease causes early immobility and often death by early adulthood. PKAN is caused by mutations in one of four human pantothenate kinase genes, PANK2 gene, which encodes a mitochondrial pantothenate kinase. Consistent with the clinical ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  6. A Mobile Health Application to Detect Absence Seizures using Hyperventilation and Eye-Movement Recordings

    SBC: Eysz, Inc.            Topic: NINDS

    Abstract Eysz, Inc. is developing a mobile health (mHealth) application and algorithms for diagnosing and monitoring absence epilepsy remotely. Accurate diagnosis and monitoring of seizures and therapeutic effects are critical elements of effective epilepsy treatment. Unfortunately, absence seizures are notoriously difficult to identify, leading to diagnostic delay and difficulty monitoring treatm ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Title: Development and Validation of Therapy for GM1 Gangliosidosis

    SBC: TEGA THERAPEUTICS INC            Topic: 107

    PROJECT SUMMARY GM1 gangliosidosis is lysosomal storage disease in which a key hydrolase enzyme, known as beta- galactosidase is missing in the lysosome resulting in the toxic accumulation of complex sugars called gangliosides, in particular GM1 and GA1 principally in the central nervous system. There is currently no cure or effective treatment available. A primary approach for treating related ty ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Genomic marker to distinguish aggressive and indolent prostate cancer

    SBC: Biomarker Corporation            Topic: 102

    ABSTRACT Prostate cancer is the most commonly diagnosed cancer in men, with an estimated 268,490 new cases in the U.S. in 2022. At the time of a prostate cancer biopsy, pathologists use the tumor material to determine the grade and stage. Primary treatment decisions are based on the biopsy tissue information and the PSA (prostate specific antigen, blood test). About 80% of newly diagnosed cases ar ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Microsatellite Instability Sequencing via Single-Molecule DNA Re-Reading

    SBC: ELECTRONIC BIOSCIENCES, INC.            Topic: 102

    Project Summary Oncologists have a great need for improved DNA sequencing technology because sequencing the DNA of cancer cells can provide valuable information about the specific mutations driving the disease and inform/guide treatment decisions. Additionally, sequencing healthy tissue can provide information about an individual's genetic risk factors for cancer. One area of particular interest i ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Biomechanical Evaluation of a Novel, Compliant Low Profile Prosthetic Foot

    SBC: LITTLE ROOM INNOVATIONS LLC            Topic: NICHD

    PROJECT SUMMARYWhile conventional wisdom holds that individuals with longer residual limbs retain greater function, they are actually confined to low-profile feet that limit performance. In particular, low-profile feet are often much stiffer than their standard profile counterparts. As such, many of the individuals with transtibial amputation that have long residual limbs are unable to obtain pros ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government